British American Tobacco’s Vuse Becomes Second E-Cig To Seek FDA Approval
The FDA moves at a glacial pace
British American Tobacco (NYSE:BTI) is just the second electronic cigarette manufacturer to submit a premarket tobacco application (PMTA) to the Food and Drug Administration. However, because the regulatory agency mandated that manufacturers not only detail how their devices are made, but also that they include scientific backing proving they improve public health, British American’s application for its Vuse e-cig included more than 150,000 pages of documentation to support it.
That underscores the monumental task other e-cig makers face as they approach the May 2020 deadline the FDA set for all manufacturers to meet if they want their product to remain on the market. The hurdle may have been set so high that only the largest tobacco companies with the deepest pockets will be able to comply.
To Read The Rest Of This Article On Motley Fool, Click Here
